ATC Group: J01DC04 Cefaclor

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J01DC04 in the ATC hierarchy

Level	Code	Title
`1`	J	Antiinfectives for systemic use
`2`	J01	Antibacterials for systemic use
`3`	J01D	Other beta-lactam antibacterials
`4`	J01DC	Second-generation cephalosporins
`5`	J01DC04	Cefaclor

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
ORAL	Oral	1 g

Active ingredients in J01DC04

Active Ingredient
Cefaclor
Cefaclor is a second-generation cephalosporin antibiotic. Cefaclor has no activity against Pseudomonas species or Acinetobacter species. Methicillin-resistant staphylococci and most strains of enterococci (eg, Str. faecalis) are resistant to cefaclor.

Related product monographs

Document	Type	Information Source
CECLOR Granules	MPI, EU: SmPC	Medicines Authority (MT)
DISTACLOR Capsule	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
MEDOCLOR Hard capsule, Granules for oral suspension	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
SYNTOCLOR Hard capsule	MPI, EU: SmPC	Υπουργείο Υγείας (CY)